These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 9835492)

  • 1. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.
    Franz R; Kelly SL; Lamb DC; Kelly DE; Ruhnke M; Morschhäuser J
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3065-72. PubMed ID: 9835492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic basis of fluconazole resistance development in Candida albicans.
    Morschhäuser J
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):240-8. PubMed ID: 12084466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
    Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
    Favre B; Didmon M; Ryder NS
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2715-25. PubMed ID: 10537193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
    J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
    White TC
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1482-7. PubMed ID: 9210670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of fluconazole resistance development in Candida albicans.
    Franz R; Ruhnke M; Morschhäuser J
    Mycoses; 1999; 42(7-8):453-8. PubMed ID: 10546486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D; Ischer F; Koymans L; Bille J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient.
    Maebashi K; Kudoh M; Nishiyama Y; Makimura K; Kamai Y; Uchida K; Yamaguchi H
    Microbiol Immunol; 2003; 47(2):117-24. PubMed ID: 12680714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
    Marichal P; Koymans L; Willemsens S; Bellens D; Verhasselt P; Luyten W; Borgers M; Ramaekers FCS; Odds FC; Vanden Bossche H
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2701-2713. PubMed ID: 10537192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Lopez-Ribot JL; McAtee RK; Lee LN; Kirkpatrick WR; White TC; Sanglard D; Patterson TF
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2932-7. PubMed ID: 9797228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
    Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
    Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains.
    Löffler J; Einsele H; Hebart H; Schumacher U; Hrastnik C; Daum G
    FEMS Microbiol Lett; 2000 Apr; 185(1):59-63. PubMed ID: 10731607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug.
    Venkateswarlu K; Denning DW; Manning NJ; Kelly SL
    FEMS Microbiol Lett; 1995 Sep; 131(3):337-41. PubMed ID: 7557345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
    Rosana Y; Yasmon A; Lestari DC
    J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
    Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P
    Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
    Jia W; Zhang H; Li C; Li G; Liu X; Wei J
    BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.